KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 117 filers reported holding KYMERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,637,289 | -49.6% | 189,733 | +7.5% | 0.00% | -66.7% |
| Q2 2023 | $5,230,526 | 0.0% | 176,528 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,230,526 | +16.7% | 176,528 | -1.7% | 0.00% | +50.0% |
| Q4 2022 | $4,481,992 | -99.9% | 179,567 | +7.2% | 0.00% | 0.0% |
| Q3 2022 | $3,647,453,000 | -4.7% | 167,545 | -13.8% | 0.00% | 0.0% |
| Q2 2022 | $3,826,240,000 | -79.0% | 194,324 | -54.8% | 0.00% | -75.0% |
| Q1 2022 | $18,207,883,000 | +7.8% | 430,243 | +61.7% | 0.01% | +33.3% |
| Q4 2021 | $16,891,578,000 | +8.0% | 266,051 | -0.1% | 0.01% | 0.0% |
| Q3 2021 | $15,641,817,000 | +14.4% | 266,289 | -5.6% | 0.01% | 0.0% |
| Q2 2021 | $13,678,893,000 | – | 282,039 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |